Drug discovery has traditionally been a reductive process—narrowing down, filtering out, and optimizing within established ...

Makary pointed to three bottlenecks: hospital contracting; ethical reviews and approvals; and the Investigational New Drug ...

Discover the impact of digital pathology on drug discovery and biomarker research this International Women’s Day with Dr ...

Data from BridgeBio Pharma’s Phase 3 FORTIFY study show that BBP-418 significantly increases levels of a key disease biomarker that helps stabilize muscles in patients with limb-girdle muscular ...

Find out how self-driving labs utilise data-driven approaches to enhance drug discovery efficiency and innovation.

Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than toxic chemicals—a discovery that could accelerate and improve how medicines ...

Over the past decade, the economics of drug development have become increasingly unforgiving. Global pharmaceutical R&D spending now exceeds $300 billion annually, yet bringing a new therapy to market ...

AbbVie’s foray into the obesity space is successful so far, analysts agree, as amylin analog ABBV-295 elicited as much as 9.73% weight loss at 13 weeks in the multiple ascending dose portion of a ...

Using AI to assemble real-world COPD data can help to identify specific clinical traits faster and with greater accuracy than traditional data sources This collaboration supports Tessel's drug ...

The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...

BASEL, Switzerland--(BUSINESS WIRE)--Indivi and Clouds of Care, two independent TechBio companies, today announced a strategic partnership to advance the use of precision medicine tools in early-phase ...

An experimental weight loss drug from Eli Lilly & Co. helped patients lose weight with few side effects, according to the summary of a small study that suggests the company has another foothold in the ...